Introduction
============

Since their commercial introduction in the early 2000s, femtosecond lasers have become increasingly more sophisticated in how they deliver photodisruptive energy to create a LASIK (laser-assisted in situ keratomileusis) flap. The first commercially available system delivered pulses at a rate of 6 kHz, which required a relatively large spot size and a high energy level per pulse. Subsequent systems introduced 10, 15, 30, 60, 150 kHz, and even higher frequencies. Higher frequencies permitted smaller spot sizes and lower pulse energies. In addition to the obvious benefits of shorter suction times, faster lasers offered the prospect of a "cleaner cut", including the promise of less inflammation caused by laser-related tissue necrosis and a smoother interface.[@b1-opth-10-1691]--[@b3-opth-10-1691] Advancements in laser technology also ushered in the possibility of more sophisticated side-cut architecture.

The IntraLase FS 60 kHz system (Abbott Medical Optics, Santa Ana, CA, USA) is a femtosecond laser commonly used for flap creation in LASIK. Its successor is the IntraLase iFS 150 kHz, which in addition to being faster -- taking about 12 seconds to cut a 9 mm flap compared to 30 seconds -- is also capable of making flaps with an inverted side-cut up to an angle of 150°. By comparison, the IntraLase FS 60 kHz cuts flaps at a conventional 70° angle ([Figure 1](#f1-opth-10-1691){ref-type="fig"}).

Only a few studies have compared the faster speed and advanced side-cut architecture offered by the iFS 150 kHz system to the popular FS 60 kHz system, but none of them have analyzed self-reported quality of vision (QoV) outcomes. Contralateral comparison of the two systems has shown that the iFS 150 kHz laser yields faster recovery of uncorrected distance visual acuity (UDVA) at 1 week, but equivalent UDVA compared to the FS 60 kHz at 1 year.[@b4-opth-10-1691] The iFS 150 kHz has also been shown to provide faster recovery of corneal sensation with a 130° inverted side-cut compared to the FS-60's conventional side-cut; however, dry eye symptoms showed no statistically significant difference between the groups.[@b5-opth-10-1691]

Methods
=======

In this prospective, randomized, eye-to-eye study, we compare the 150 kHz and 60 kHz laser systems in contralateral eyes with myopia. The primary outcome measure at Months 1, 3, 6, and 12 was self-reported QoV measured by the validated 30-point QoV[@b6-opth-10-1691] questionnaire.

This prospective, comparative study adhered to the tenets of the Declaration of Helsinki as well as the Health Insurance Portability and Accountability Act and was conducted at the Stanford Eye Laser Center after receiving Stanford University Institutional Review Board approval. All patients provided their written informed consent after full disclosure of the nature of the research.

A computer-generated randomization schedule was used to assign the dominant eye to have LASIK flap creation with either the 60 kHz IntraLase FS or the 150 kHz IntraLase iFS. The fellow eye was treated with the alternative femtosecond laser.

Inclusion criteria were a stable refraction with a change of less than 0.50 diopters (D) of sphere or cylinder in the last year, discontinuation of soft contact lens wear at least 1 week before the preoperative evaluation, best-corrected visual acuity of 20/20 or better, age older than 21 years, and ability to participate in postoperative examinations for at least 12 months.

Exclusion criteria included use of rigid gas permeable contact lenses, severe dry eye or blepharitis, corneal pathology (ie, recurrent erosion syndrome, basement membrane disease, keratoconus, and irregular corneal mires on central keratometry), pachymetry whereby the postoperative thickness would be less than 250 μm below the flap, baseline standard manifest refraction with a difference of 0.75 D or more in sphere power or 0.50 D in cylinder power as compared to the baseline standard cycloplegic refraction, history of herpes zoster or herpes simplex, corneal warpage (ie, contact lens-induced topographical abnormalities), and certain systemic diseases or conditions (ie, connective tissue disease, diabetes, pregnancy, lactation, immunocompromised state, and severe atopy). Also excluded were patients with sensitivity to the study's concomitant medications and patients participating in a clinical trial for another ophthalmic drug or device.

Patients meeting these criteria underwent a comprehensive preoperative evaluation, including history, manifest, and cycloplegic refraction using the Early Treatment Diabetic Retinopathy Study charts, 5% and 25% contrast sensitivity (Precision Vision, La Salle, IL, USA), slit-lamp biomicroscopy, dilated fundus examination, Goldmann applanation tonometry, infrared pupillometry (Neuroptics, Irvine, CA, USA), computerized corneal topography, and wavefront aberrometry using the WaveScan® (Abbott Medical Optics).

All surgeries were performed at Stanford University Eye Laser Center by a single surgeon (EEM). Topical proparacaine hydrochloride 0.5% (Ophthetic), moxifloxacin hydrochloride ophthalmic solution 0.5% (Alcon, Fort Worth, TX, USA), and ketorolac tromethamine ophthalmic solution 0.4% (Acular LS) were administered immediately before the procedure.

Flaps were created using settings consistent with the usual practice at the laser center. Specifically, flaps created using the 150 kHz laser had a 9.0 mm diameter, superior hinge, 105 μm programmed flap thickness, and 130° inverted side-cut angle. The bed's spot and line separation was 7 μm, with a pulse energy of 0.75 μJ, and the side-cut's spot and line separation was 5 μm, with a pulse energy of 0.75 μJ. Flaps created using the 60 kHz system had the same orientation and dimensions, but with a different side-cut profile of 70°. The bed's spot and line separation was 7 μm, with a pulse energy of 1.0 μJ, and the side-cut's spot and line separation was 5 μm, with a pulse energy of 1.0 μJ.

Bilateral flaps were made before refractive treatment with the Customvue S4 IR excimer laser system (Abbott Medical Optics). To eliminate a potential effect from second eye surgery, an equal number of patients had their first flap made with the 60 kHz and 150 kHz femtosecond lasers. Flaps were marked for alignment, lifted, and repositioned manually after the ablation treatment. Postoperative medications were topical moxifloxacin (Vigamox) four times daily for 4 days and prednisolone acetate 1.0% (Predforte) four times daily for 7 days.

Measurement of self-reported quality of vision
----------------------------------------------

Patients completed the QoV questionnaire, which is a validated, Rasch-tested, linear-scaled 30-item instrument developed by McAlinden et al,[@b6-opth-10-1691] who consider it suitable for measuring QoV in patients with all types of refractive correction, eye surgery, and eye disease. The instrument measures ten parameters along with the three subscales in terms of symptom frequency, severity, and the degree to which the symptom is bothersome. Each subscale comprises a question, which is answered by the patient, and has a score ranging from 0, indicating never or not at all, to 3, indicating very often or severe ([Table 1](#t1-opth-10-1691){ref-type="table"}). Scores for each question are summed into a composite score; higher composite scores indicate poorer QoV. The parameters measured by the instrument are glare, haloes, starbursts, hazy vision, blurred vision, distortion, double or multiple images, fluctuation in vision, focusing difficulties, and difficulties judging distance or depth perception. The first seven of these parameters are paired with an image chosen by the authors of the instrument to reduce the possibility of inconsistent responses. The instrument was administered in a bilateral simultaneous fashion preoperatively and at 1, 3, 6, and 12 months after LASIK.

Statistics
----------

Statistical analyses were performed with commercially available software packages (SPSS for Mac, version 20.0; SPSS, Inc., Chicago, IL, USA and Stata for Mac, version 13.0; StataCorp LP, College Station, TX, USA). Normal distribution was assessed with the Shapiro--Wilk test. Comparisons of means were performed using a paired test; normally distributed data were analyzed with a paired *t*-test, and nonnormally distributed data were analyzed with a Wilcoxon signed-rank test, which is the nonparametric analog of the paired *t*-test. Correlations between binary variables were calculated using Pearson's chi-square test. *P*-values were two-sided and considered statistically significant when less than 0.05.

Results
=======

One hundred and twenty eyes of 60 patients were enrolled in the study. The mean age of the patients was 34.3±9.0 years, and 63.9% of the cohort was female. Preoperative data showed no statistically significant differences between the groups in all studied parameters, including corrected distance visual acuity, manifest sphere and cylinder, manifest spherical equivalent, coma, trefoil, spherical aberration, and root mean square error (all *P*\>0.05, [Table 2](#t2-opth-10-1691){ref-type="table"}). There was also no statistically significant difference in the proportion of distance dominant eyes randomized to the iFS 150 kHz laser (*P*=0.86). There were no intraoperative or postoperative complications.

None of the QoV parameters exhibited statistically significant differences preoperatively or at postoperative Months 1, 3, 6, and 12. Most parameters exhibited parallel trends of stability between the groups or statistically insignificant improvement between the preoperative and 12-month follow-up, with the exception of hazy vision and vision fluctuation. For the latter questionnaire parameters, there were different trends in each group, but they were small and statistically insignificant. For the Bothersome subscale of Hazy Vision, the mean rating improved (ie, decreased) between the preoperative and 12-month assessments in the FS 60 kHz group, whereas it worsened (ie, increased) in the iFS 150 kHz group. For the Frequency subscale of Vision Fluctuation, the FS 60 kHz group's mean improved over 1 year, whereas the iFS 150 kHz group's mean remained stable. Similarly, for the Severity subscale of Vision Fluctuation, the FS 60 kHz group's mean improved, whereas the iFS 150 kHz group's mean worsened. However, none of these trends were statistically significant (all *P*\>0.05, [Figures 2](#f2-opth-10-1691){ref-type="fig"} and [3](#f3-opth-10-1691){ref-type="fig"}; [Table 3](#t3-opth-10-1691){ref-type="table"}).

Discussion
==========

QoV after refractive surgery is an area of growing interest.[@b7-opth-10-1691]--[@b10-opth-10-1691] We conducted a prospective, comparative fellow eye study of 120 eyes in 60 patients who underwent femtosecond-assisted myopic LASIK to evaluate the effect of two different laser systems on QoV using the QoV questionnaire.[@b6-opth-10-1691] To the best of our knowledge, this is the first clinical study to compare femtosecond laser systems on the basis of self-reported QoV.

This study is a companion to three other investigations that have recently been published by our group, all of which have compared the FS 60 kHz to the iFS 150 kHz femtosecond lasers in fellow eyes of the same cohort of patients.[@b4-opth-10-1691],[@b5-opth-10-1691],[@b11-opth-10-1691] The first study by Kung et al[@b5-opth-10-1691] focused on the advanced side-cut capabilities of the iFS 150 kHz system, comparing a 130° inverted profile to a conventional 70° profile made with the FS 60 kHz system. The study found a significantly faster recovery of corneal sensation in eyes with an inverted side-cut without a corresponding improvement in self-reported dry eye symptoms; it was limited by omission of a standardized assessment of the ocular surface for dryness, which may or may not have had a stronger correlation with esthesiometry.[@b6-opth-10-1691] Yu and Manche[@b4-opth-10-1691] subsequently published a second study of the same cohort that observed a short-term advantage in UDVA conferred by the iFS 150 kHz that was present at 1 week (85% vs 71% achieved 20/16 or better, *P*\<0.05) but absent thereafter up to the study's 1-year follow-up. All other parameters, including contrast sensitivity and higher-order aberrations, were also equivalent between the lasers. Finally, Yu and Manche[@b11-opth-10-1691] published a third study of this cohort that showed equivalence between the laser platforms with respect to flap thickness accuracy and uniformity.

As they pertain to this study, the substantive differences between the FS 60 kHz and iFS 150 kHz lasers are the pulse frequency (60 vs 150 kHz), the energy per pulse (1.0 vs 0.75 μJ), and the side-cut angle of the flap (70° vs 130°). It is known from histopathologic and confocal studies that higher frequency, lower energy pulses cause less tissue necrosis and render a smoother stromal bed compared to lower frequency, higher energy pulses.[@b2-opth-10-1691],[@b12-opth-10-1691] Thus, at least in theory, one could reasonably postulate that the iFS 150 kHz system might improve visual outcomes after LASIK.

The results published by Yu and Manche[@b11-opth-10-1691] showing faster recovery of UDVA at 1 week with the iFS 150 kHz laser may support such a postulate, but it also raises compelling questions about why the advantage was not retained at subsequent follow-ups. Was the initial superiority of UDVA delivered by the iFS 150 kHz laser due to less inflammation and a smoother interface from its lower pulse energy, or was it due to a more regular ocular surface and/or a more stable flap from its inverted side-cut?

The possibility that there was less inflammation in the iFS group is reasonable in light of the known decrement in UDVA associated with diffuse lamellar keratitis (DLK) in the immediate postoperative period.[@b13-opth-10-1691] Choe et al[@b14-opth-10-1691] showed equivalent frequencies of DLK in eyes with flaps made by the FS 15 kHz, FS 30 kHz, and FS 60 kHz systems, but others have shown increased risk of DLK in a comparison between the FS 60 kHz laser and the Femto LDV laser, which has a repetition rate faster than 5 mHz.[@b15-opth-10-1691] However, Yu and Manche[@b11-opth-10-1691] reported no instances of DLK in their series, making this possibility moot.

A smoother interface is another potential explanation, with the caveat that perhaps a "rougher" stromal interface rendered by the slower FS 60 kHz system smoothens over time due to remodeling.[@b16-opth-10-1691] Were this true, it might explain the trend toward equivalence of UDVA between the FS 60 kHz and iFS 150 kHz systems 1 year after an initial advantage in the latter group. Supporting this explanation are the handful of studies that have confirmed through masked observation that stromal beds are indeed smoother with lower pulse energies delivered by a higher frequency laser.[@b1-opth-10-1691],[@b17-opth-10-1691]

There are also data substantiating the premise that pulse energy may have a threshold effect on bed smoothness. A study by Kymionis et al[@b17-opth-10-1691] showed that the iFS 150 kHz laser delivered equivalent smoothness compared to the Wavelight FS 200 kHz laser, suggesting that above a certain frequency (and below a certain pulse energy), there are diminishing effects on the stromal bed and flap interface. By contrast, a study by Sarayba et al[@b1-opth-10-1691] showed a smoother stromal surface with a 30 kHz laser (1.2 μJ raster energy) compared to a 15 kHz laser (2 μJ raster energy). A difference of only 0.25 μJ between the laser systems studied in the present investigation could certainly contribute to an explanation of why there might be no observed difference in QoV.

The observation from the study by Kung et al[@b5-opth-10-1691] that an inverted side-cut made with the iFS 150 kHz laser conferred faster recovery of sensation without an improvement in dry eye symptoms may also partially explain the absence of a difference in QoV compared to the FS 60 kHz laser. Dry eye is associated with impaired functional visual acuity as well as decreased QoV,[@b18-opth-10-1691]--[@b20-opth-10-1691] and is one of the most common side effects of LASIK surgery. Multiple studies have implicated disrupted corneal sensation as the culprit behind post-LASIK dry eye.[@b21-opth-10-1691]--[@b24-opth-10-1691] Severing corneal nerves when cutting the LASIK flap disrupts neurosensory feedback for tear formation and osmolarity homeostasis, which, in turn, causes neurotrophic corneal epitheliopathy.[@b25-opth-10-1691],[@b26-opth-10-1691] LASIK flaps made with a femtosecond laser have been associated with decreased dry eye and longer tear break up times compared to flaps made with a microkeratome.[@b27-opth-10-1691]--[@b29-opth-10-1691] However, the negative findings of the present study suggest that even if superior side cut architecture does indeed provide improved wound healing and ocular surface homeostasis, these biomechanical advantages may not translate to improved subjective QoV. The latter postulate agrees with the conclusions made by prior studies, which have not demonstrated consistent associations between objective and subjective correlates of dry eye following LASIK.[@b30-opth-10-1691],[@b31-opth-10-1691]

Results from the study by Kung et al[@b5-opth-10-1691] also raise the possibility of an alternative explanation to the faster recovery of UDVA in the iFS 150 kHz group and absence of any difference in QoV - biomechanical flap stability. A more stable and anatomically positioned flap conferred by the inverted side-cut[@b32-opth-10-1691],[@b33-opth-10-1691] might be the best explanation for faster visual recovery with the iFS 150 kHz laser at 1 week; however, this postulate requires further investigation. Future studies should control for the effect of frequency and pulse energy by comparing the 70° side-cuts made with the iFS 150 kHz to the 130° side-cuts made with the same laser. The iFS 150 kHz system should also be compared to the FS 60 kHz system using a 70° side-cut to ascertain the effect of a 0.25 μJ difference in pulse energy with a frequency difference of 90 kHz. In all these studies, the ocular surface must be controlled for with systematized grading of superficial punctate keratopathy and tear film, which were not controlled for in any of our group's comparative studies of the iFS 150 kHz and FS 60 kHz lasers to date.

The most important strength of this study is that it randomized contralateral eyes in the same individual because fellow eyes are more likely to demonstrate similar corneal biomechanical properties and wound healing as compared to eyes from different individuals. Other strengths of this study are the length of prospective follow-up to 1 year and the use of a validated Rasch-tested measuring instrument to evaluate self-reported QoV. The obvious limitation to consider is the use of different laser platforms -- the 60 kHz IntraLase FS was used for the 70° side-cut, while the 150 kHz IntraLase iFS was used for the 130° inverted side-cut. On the other hand, comparing these two platforms is likely more reflective of the real-world progression faced by refractive surgeons considering newer technologies. Finally, it is possible that our measuring instrument was insufficiently sensitive to resolve differences between the two eyes and that the study was inadequately powered to detect significance for the QoV parameters. Recall bias may have also affected the results, with the majority of patients tending to select the same answer for both eyes as well as give positive ratings in accordance with general satisfaction with their improved UDVA.

Conclusion
==========

In summary, we found that a 130° inverted side cut LASIK flap made with a 0.25 μJ lower pulse energy using the iFS 150 kHz laser was not associated with any statistically significant differences in self-reported QoV as measured by the QoV questionnaire over 12 months of follow-up compared to a conventional 70° side cut made with the FS 60 kHz laser.

Abbott Medical Optics, Inc. provided an unrestricted grant to partially fund this clinical trial.
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![Schematic of inverted, left, vs conventional, right, side cut LASIK flaps.\
**Abbreviation:** LASIK, laser-assisted in situ keratomileusis.](opth-10-1691Fig1){#f1-opth-10-1691}

![Self-reported QoV outcomes after femtosecond-assisted myopic LASIK with either a 130° inverted side-cut made with a 150 kHz laser or a 70° conventional side cut made with a 60 kHz laser (QoV items 1--15).\
**Note**: All *P*\>0.05.\
**Abbreviations**: QoV, quality of vision; LASIK, laser-assisted in situ keratomileusis; pre-op, pre-operative.](opth-10-1691Fig2){#f2-opth-10-1691}

![Self-reported QoV outcomes after femtosecond-assisted myopic LASIK with either a 130° inverted side-cut made with a 150 kHz laser or a 70° conventional side-cut made with a 60 kHz laser (QoV items 16--30).\
**Note**: All *P*\>0.05.\
**Abbreviations**: QoV, quality of vision; LASIK, laser-assisted in situ keratomileusis; pre-op, pre-operative.](opth-10-1691Fig3){#f3-opth-10-1691}

###### 

Quality of vision questionnaire

  Parameter                                                                                                     Subscale question and response scale
  ------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------
  Glare                                                                                                         1\. How often do you experience glare? Never (0) -- Very often (3)
  2\. How severe is the glare? Not at all (0) -- Severe (3)                                                     
  3\. How bothersome is the glare? Not at all (0) -- Very (3)                                                   
  Haloes                                                                                                        4\. How often do you experience haloes? Never (0) -- Very often (3)
  5\. How severe are the haloes? Not at all (0) -- Severe (3)                                                   
  6\. How bothersome are the haloes? Not at all (0) -- Severe (3)                                               
  Starbursts                                                                                                    7\. How often do you experience starbursts? Never (0) -- Very often (3)
  8\. How severe are the starbursts? Not at all (0) -- Severe (3)                                               
  9\. How bothersome are the starbursts? Not at all (0) -- Severe (3)                                           
  Hazy vision                                                                                                   10\. How often do you experience hazy vision? Never (0) -- Very often (3)
  11\. How severe is the hazy vision? Not at all (0) -- Severe (3)                                              
  12\. How bothersome is the hazy vision? Not at all (0) -- Severe (3)                                          
  Blurred vision                                                                                                13\. How often do you experience blurred vision? Never (0) -- Very often (3)
  14\. How severe is the blurred vision? Not at all (0) -- Severe (3)                                           
  15\. How bothersome is the blurred vision? Not at all (0) -- Severe (3)                                       
  Distortion                                                                                                    16\. How often do you experience distortion? Never (0) -- Very often (3)
  17\. How severe is the distortion? Not at all (0) -- Severe (3)                                               
  18\. How bothersome is the distortion? Not at all (0) -- Severe (3)                                           
  Double or multiple images                                                                                     19\. How often do you experience double or multiple images? Never (0) -- Very often (3)
  20\. How severe are the double or multiple images? Not at all (0) -- Severe (3)                               
  21\. How bothersome are the double or multiple images? Not at all (0) -- Severe (3)                           
  Fluctuation in your vision                                                                                    22\. How often do you experience fluctuation in your vision? Never (0) -- Very often (3)
  23\. How severe is the fluctuation in your vision? Not at all (0) -- Severe (3)                               
  24\. How bothersome is the fluctuation in your vision? Not at all (0) -- Severe (3)                           
  Focusing difficulties                                                                                         25\. How often do you experience focusing difficulties? Never (0) -- Very often (3)
  26\. How severe are the focusing difficulties? Not at all (0) -- Severe (3)                                   
  27\. How bothersome are the focusing difficulties? Not at all (0) -- Severe (3)                               
  Difficulties judging distance or depth perception                                                             28\. How often do you have difficulty judging distance or depth perception? Never (0) -- Very often (3)
  29\. How severe are the difficulties judging distance or depth perception? Not at all (0) -- Severe (3)       
  30\. How bothersome are the difficulties judging distance or depth perception? Not at all (0) -- Severe (3)   

**Notes:** The QoV questionnaire is a Rasch-tested, linear-scaled (0--3) 30-item instrument on three scales providing a QoV score in terms of symptom frequency, severity, and the degree to which the symptom is bothersome. McAlinden et al[@b6-opth-10-1691] developed the instrument and consider it suitable for measuring QoV in patients with all types of refractive correction, eye surgery, and eye disease. The instrument and further details pertaining to its development can be found in McAlinden et al.[@b6-opth-10-1691]

**Abbreviation:** QoV, quality of vision.

###### 

Cohort demographics and preoperative clinical parameters

  Parameter                          Mean ± SD (range) or % (95% CI)   *P*-value[a](#tfn3-opth-10-1691){ref-type="table-fn"}   
  ---------------------------------- --------------------------------- ------------------------------------------------------- --------------------------------------------------
  Demographics                                                                                                                 
   Age, years                        34.3±9.0 (21 to 75)                                                                       
   Female                            63.9% (51.0 to 76.8)                                                                      
   Right eye                         59.0% (45.8 to 72.2)              41.0% (27.8 to 54.2)                                    0.05[b](#tfn4-opth-10-1691){ref-type="table-fn"}
   Dominant eye                      50.8% (37.4 to 64.2)              49.2% (35.8 to 62.6)                                    0.86[b](#tfn4-opth-10-1691){ref-type="table-fn"}
  Preoperative clinical parameters                                                                                             
   CDVA (logMAR)                     −0.14±0.07 (−0.30 to 0.00)        −0.14±0.07 (−0.20 to 0.00)                              0.82
   Manifest sphere                   −4.62±2.32 (−9.75 to −1.00)       −4.66±2.30 (−10.00 to −0.75)                            0.73
   Manifest cylinder                 +0.65±0.49 (0.00 to 1.75)         +0.69±0.70 (0.00 to 3.00)                               0.57
   Manifest SE                       −4.30±2.31 (−9.75 to −0.88)       −4.32±2.31 (−10.00 to −0.75)                            0.85
   Coma                              0.19±0.10 (0.05 to 0.45)          0.18±0.09 (0.03 to 0.44)                                0.33
   Trefoil                           0.16±0.09 (0.02 to 0.45)          0.17±0.08 (0.01 to 0.35)                                0.55
   Spherical aberration              0.09±0.12 (−0.19 to 0.40)         0.09±0.12 (−0.26 to 0.35)                               0.79
   RMS error                         0.34±0.11 (0.17 to 0.58)          0.34±0.09 (0.11 to 0.58)                                0.61

**Notes:**

*P*-values are calculated using the paired t-test unless otherwise specified.

*P*-values are calculated using the Pearson's chi-square test.

**Abbreviations**: CDVA, corrected distance visual acuity; CI, confidence interval; logMAR, logarithm of the minimum angle of resolution; RMS, root mean square; SD, standard deviation; SE, spherical equivalent.

###### 

Quality of vision questionnaire results before and after myopic femtosecond laser-assisted in situ keratomileusis with 2 femtosecond lasers

  Parameter               Preoperative   1 month   3 months   6 months   12 months                                                                  
  ----------------------- -------------- --------- ---------- ---------- ----------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  Glare                                                                                                                                             
   1. Frequency           0.53           0.53      1.00       0.78       0.78        1.00   0.63   0.65   0.32   0.50   0.50   1.00   0.48   0.48   1.00
   2. Severity            0.51           0.51      1.00       0.76       0.76        1.00   0.61   0.63   0.32   0.43   0.43   1.00   0.39   0.39   1.00
   3. Bothersome          0.29           0.31      0.32       0.51       0.51        1.00   0.40   0.40   1.00   0.38   0.38   1.00   0.30   0.30   1.00
  Haloes                                                                                                                                            
   4. Frequency           0.64           0.64      1.00       1.02       1.02        1.00   0.54   0.56   0.56   0.47   0.47   1.00   0.41   0.41   1.00
   5. Severity            0.57           0.57      1.00       0.83       0.83        1.00   0.44   0.47   0.16   0.36   0.36   1.00   0.31   0.31   1.00
   6. Bothersome          0.40           0.40      1.00       0.58       0.58        1.00   0.32   0.32   1.00   0.24   0.24   1.00   0.20   0.20   1.00
  Starbursts                                                                                                                                        
   7. Frequency           0.67           0.67      1.00       0.66       0.66        1.00   0.60   0.61   0.32   0.43   0.45   0.32   0.44   0.44   1.00
   8. Severity            0.59           0.59      1.00       0.54       0.54        1.00   0.47   0.49   0.32   0.38   0.40   0.32   0.38   0.38   1.00
   9. Bothersome          0.38           0.38      1.00       0.32       0.32        1.00   0.25   0.27   0.32   0.21   0.21   1.00   0.20   0.20   1.00
  Hazy vision                                                                                                                                       
  10\. Frequency          0.12           0.14      0.32       0.53       0.54        0.78   0.35   0.35   1.00   0.28   0.28   1.00   0.26   0.20   0.46
  11\. Severity           0.10           0.14      0.32       0.37       0.38        1.00   0.33   0.33   1.00   0.22   0.22   1.00   0.25   0.18   0.10
  12\. Bothersome         0.09           0.12      0.32       0.39       0.42        0.48   0.26   0.26   1.00   0.17   0.17   1.00   0.18   0.11   0.10
  Blurred vision                                                                                                                                    
  13\. Frequency          0.60           0.62      0.56       0.58       0.61        0.41   0.49   0.49   1.00   0.53   0.53   1.00   0.49   0.48   0.56
  14\. Severity           0.60           0.64      0.41       0.51       0.53        0.56   0.42   0.42   1.00   0.46   0.47   0.32   0.44   0.43   0.56
  15\. Bothersome         0.47           0.50      0.41       0.51       0.53        0.56   0.40   0.40   1.00   0.41   0.43   0.32   0.46   0.44   0.56
  Distortion                                                                                                                                        
  16\. Frequency          0.07           0.07      1.00       0.08       0.08        1.00   0.07   0.07   1.00   0.02   0.02   1.00   0.02   0.02   1.00
  17\. Severity           0.07           0.07      1.00       0.07       0.07        1.00   0.05   0.05   1.00   0.00   0.00   1.00   0.02   0.02   1.00
  18\. Bothersome         0.07           0.07      1.00       0.07       0.07        1.00   0.04   0.04   1.00   0.02   0.02   1.00   0.02   0.02   1.00
  Multiple images                                                                                                                                   
  19\. Frequency          0.16           0.16      1.00       0.10       0.12        0.32   0.09   0.09   1.00   0.05   0.05   1.00   0.11   0.10   0.32
  20\. Severity           0.12           0.12      1.00       0.08       0.10        0.32   0.09   0.09   1.00   0.03   0.03   1.00   0.11   0.10   0.32
  21\. Bothersome         0.17           0.17      1.00       0.10       0.12        0.32   0.09   0.09   1.00   0.02   0.02   1.00   0.10   0.10   1.00
  Vision fluctuation                                                                                                                                
  22\. Frequency          0.43           0.45      0.32       0.66       0.68        0.66   0.54   0.53   0.32   0.43   0.45   0.32   0.43   0.38   0.08
  23\. Severity           0.34           0.36      0.32       0.56       0.58        0.66   0.49   0.47   0.32   0.31   0.33   0.32   0.38   0.34   0.16
  24\. Bothersome         0.22           0.22      1.00       0.41       0.41        1.00   0.33   0.32   0.32   0.24   0.26   0.32   0.30   0.26   0.16
  Focusing dif.                                                                                                                                     
  25\. Frequency          0.90           0.91      0.32       0.75       0.78        0.41   0.63   0.63   1.00   0.60   0.64   0.16   0.46   0.46   1.00
  26\. Severity           0.74           0.76      0.32       0.58       0.59        0.56   0.53   0.53   1.00   0.48   0.52   0.16   0.39   0.39   1.00
  27\. Bothersome         0.71           0.74      0.32       0.56       0.58        0.56   0.47   0.47   1.00   0.41   0.45   0.16   0.28   0.28   1.00
  Depth perception dif.                                                                                                                             
  28\. Frequency          0.57           0.57      1.00       0.15       0.15        1.00   0.21   0.21   1.00   0.17   0.19   0.32   0.11   0.13   0.32
  29\. Severity           0.50           0.50      1.00       0.12       0.12        1.00   0.16   0.16   1.00   0.12   0.14   0.32   0.11   0.13   0.32
  30\. Bothersome         0.55           0.55      1.00       0.14       0.14        1.00   0.12   0.12   1.00   0.10   0.12   0.32   0.08   0.10   0.32

**Note:**

*P*-values are calculated using Wilcoxon signed-ranks test

**Abbreviations**: dif., difficulty; CSC, conventional side cut; ISC, inverted side cut.
